{
    "ticker": "ONCO",
    "name": "OncoSec Medical Incorporated",
    "description": "OncoSec Medical Incorporated is a biotechnology company focused on the development of innovative cancer therapies. Founded in 2011 and headquartered in San Diego, California, OncoSec is dedicated to improving the treatment of cancer through its proprietary intratumoral delivery technology, which enhances the immune response against tumors. The company's leading product candidate, TAVO, is designed to deliver interleukin-12 (IL-12) directly into tumors, aiming to stimulate a systemic anti-tumor immune response. OncoSec's approach leverages the body\u2019s immune system to fight cancer more effectively, with the potential to address multiple types of cancer, including melanoma and triple-negative breast cancer. The company is actively engaged in clinical trials to evaluate the safety and efficacy of its therapies, and it collaborates with leading research institutions to advance its mission. OncoSec's vision is to transform cancer treatment by providing options that lead to better outcomes for patients while reducing the side effects associated with traditional therapies.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2011",
    "website": "https://oncosec.com",
    "ceo": "Punit Dhillon",
    "social_media": {
        "twitter": "https://twitter.com/OncoSec",
        "linkedin": "https://www.linkedin.com/company/oncosec-medical-incorporated/"
    },
    "investor_relations": "https://investors.oncosec.com",
    "key_executives": [
        {
            "name": "Punit Dhillon",
            "position": "CEO"
        },
        {
            "name": "Michael E. McGowan",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Immunotherapy",
            "products": [
                "TAVO"
            ]
        }
    ],
    "seo": {
        "meta_title": "OncoSec Medical | Innovative Cancer Therapies",
        "meta_description": "OncoSec Medical is a biotechnology company focused on developing innovative cancer therapies using intratumoral delivery technology to stimulate the immune system.",
        "keywords": [
            "OncoSec",
            "Cancer Therapy",
            "Immunotherapy",
            "Biotechnology",
            "TAVO",
            "Clinical Trials"
        ]
    },
    "faq": [
        {
            "question": "What is OncoSec known for?",
            "answer": "OncoSec is known for developing innovative cancer therapies, particularly its TAVO product candidate."
        },
        {
            "question": "Who is the CEO of OncoSec?",
            "answer": "Punit Dhillon is the CEO of OncoSec Medical Incorporated."
        },
        {
            "question": "Where is OncoSec headquartered?",
            "answer": "OncoSec is headquartered in San Diego, California, USA."
        },
        {
            "question": "What is TAVO?",
            "answer": "TAVO is OncoSec's leading product candidate designed to deliver interleukin-12 directly into tumors to stimulate an immune response."
        },
        {
            "question": "When was OncoSec founded?",
            "answer": "OncoSec was founded in 2011."
        }
    ],
    "competitors": [
        "NVS",
        "AMGN",
        "BMY",
        "REGN"
    ],
    "related_stocks": [
        "AAPL",
        "GOOGL",
        "MSFT",
        "PFE"
    ]
}